FDA Grants Humanitarian Use Device Designation to Bionaut Labs for Treatment of Dandy Walker Syndrome

LOS ANGELES: LOS ANGELES, Sept. 23, 2021 /PRNewswire/ -- Bionaut Labs, a company focused on revolutionizing the treatment of central nervous system (CNS) disorders with its Bionautâ„¢ precision medicine treatment modality, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company humanitarian use device (HUD) designation...

Click to view original post